about
Genome-wide analysis of microRNA and mRNA expression signatures in cancerVacuum-assisted breast biopsy for breast cancerGemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cellsWhy should primary care physicians know about breast cancer genetics?Using lifetime risk estimates in personal genomic profiles: estimation of uncertaintySynergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cellsTissue biomarkers of breast cancer and their association with conventional pathologic features.How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling.FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disordersIndustrialization, electromagnetic fields, and breast cancer riskKey concepts for estimating the burden of surgical conditions and the unmet need for surgical careAn analysis of breast cancer coverage in selected women's magazines, 1987-1995.Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosGrowth inhibition of human breast carcinoma cells by overexpression of regulator of G-protein signaling 4.Effect of SERMs on breast tissue.Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection.Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.Variability in short-wavelength automated perimetry among peri- or postmenopausal women: a dependence on phyto-oestrogen consumption?When is an HIV infection prevented and when is it merely delayed?Identification of racial disparities in breast cancer mortality: does scale matter?Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display.Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation.Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primariesAccelerated Partial Breast Irradiation (APBI): A review of available techniques.Racial and ethnic disparities in lifetime risk of corpus uterine cancer: a comparative study of Puerto Rico and the United States SEER populationEconomic impact of the growing population of breast cancer survivors.One in four people may develop symptomatic hip osteoarthritis in his or her lifetime.Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer.Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups.Risks and probabilities of breast cancer: short-term versus lifetime probabilities.MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?Identifying risk factors for disparities in breast cancer mortality among African-American and Hispanic women.A bivariate survival model with compound Poisson frailty.Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature.Breast cancer in Hong Kong, Southern China: the first population-based analysis of epidemiological characteristics, stage-specific, cancer-specific, and disease-free survival in breast cancer patients: 1997-2001.Breast cancer medications and vision: effects of treatments for early-stage disease.Identification of valid reference genes for the normalization of RT-qPCR expression studies in human breast cancer cell lines treated with and without transient transfection.Referral patterns, clinical examination and the two-week-rule for breast cancer: a cohort study.Multiple imputation for estimating the risk of developing dementia and its impact on survival
P2860
Q26795603-E9E1263C-D188-4AC3-82D8-3EE46189D008Q27014876-5F28FFB3-68BD-4349-9B14-E41FE802B1F3Q28297927-56982DEA-F886-46BB-9188-6CC989F23305Q28383592-8F9DDCCF-F691-41E5-A16F-ACFE28151649Q28392540-AC8EBDAC-D409-4DBD-94DD-9B3120961063Q28397373-9D20603E-4DAA-475B-ACE6-94FE37A08297Q31110635-48353479-6743-48BF-AAD3-E831EF915F47Q31159691-60B8C8DB-8524-4939-B95B-F2AACC0FADDEQ33270390-F3C33A64-2C5B-47D9-857A-47BE7E083FF3Q33608815-9C7252F1-4427-4F2B-8063-6D1412167B32Q33631412-CEEA984F-CA37-4583-B878-D60850C37C2CQ33648470-E2BD0E7E-EADA-4312-B48F-40033E5204B5Q33718335-60DA488A-5695-4E5E-A696-EB9950A4BC74Q33750766-1F1E54EC-39D2-42F5-8F97-332ABB3736CBQ33757750-E5D5A489-79B5-437E-95A8-2419A55DBA46Q33851393-BC3BDAD6-232B-4797-A6BF-2CD34BE71E14Q33923783-A7C24285-7D89-4EEB-AC41-5985404C61D9Q33926453-AADEE4C3-0C01-4A09-9766-75395F5123CAQ34007192-66F38EC5-BBF8-4158-885C-336253E07B64Q34020112-E1248CEB-839D-4833-B819-E82242964E5EQ34042492-60D7AE1D-F71F-449D-9D48-434775DF7CFCQ34146866-B457175C-C18A-4CAC-A36E-0CA579B8746DQ34162501-45E863B1-2E4C-49FB-86F3-B6E241D031AFQ34202034-BC5191D7-ADA1-4809-8BEC-72F276E383E6Q34221220-FA75F8BF-3EF1-478E-86EA-8779F8B7D829Q34223459-D721D8F1-48D3-4FCC-929C-AE28B2E27EF8Q34234553-A859AB9F-AA07-4BD4-803A-A7A51B550CA5Q34385572-DCA7ED31-3FAD-4AFF-86EE-3F7E35568F73Q34434006-728B563B-8D01-40D3-A0D3-C962C643FEEEQ34613569-9817F236-257D-4E3E-A6AA-129DBD269F92Q34707940-A2D7A50E-3576-42FD-8CDD-6C607C7AE273Q34990741-339137F9-4F8C-4DDE-923E-0E1AB3C18C3DQ35112462-EDF1B87E-E90B-4E95-AB0B-3A4A5356B10EQ35185152-642C4C88-A04B-4273-A0B9-F9380C298DF7Q35188282-E709509E-5887-4E0D-AA1C-F6AFA1A9EA0EQ35233475-E56FA5D2-F524-4E86-BE6C-C77E1D9B458BQ35496778-43DEFBF8-48A1-4914-9F3E-3F1996430CE5Q35548593-79C375CF-D592-422E-A494-8AEC38B3C956Q35590206-C4F67719-928F-4682-9752-AED13A6931B2Q35615091-E58E66AB-8444-448B-A8DE-D69EF109F1ED
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
name
The lifetime risk of developing breast cancer.
@ast
The lifetime risk of developing breast cancer.
@en
The lifetime risk of developing breast cancer.
@nl
type
label
The lifetime risk of developing breast cancer.
@ast
The lifetime risk of developing breast cancer.
@en
The lifetime risk of developing breast cancer.
@nl
prefLabel
The lifetime risk of developing breast cancer.
@ast
The lifetime risk of developing breast cancer.
@en
The lifetime risk of developing breast cancer.
@nl
P2093
P356
P1476
The lifetime risk of developing breast cancer.
@en
P2093
P304
P356
10.1093/JNCI/85.11.892
P407
P577
1993-06-01T00:00:00Z